DMC Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $808K | Sell |
7,518
-318
| -4% | -$34.2K | 0.63% | 49 |
|
|
2025
Q1 | $790K | Sell |
7,836
-63
| -0.8% | -$6.36K | 0.64% | 49 |
|
|
2024
Q4 | $706K | Buy |
7,899
+947
| +14% | +$84.6K | 0.57% | 53 |
|
|
2024
Q3 | $583K | Buy |
6,952
+1,034
| +17% | +$86.6K | 0.47% | 74 |
|
|
2024
Q2 | $456K | Buy |
5,918
+691
| +13% | +$53.2K | 0.39% | 80 |
|
|
2024
Q1 | $358K | Buy |
5,227
+312
| +6% | +$21.4K | 0.31% | 93 |
|
|
2023
Q4 | $284K | Buy |
4,915
+868
| +21% | +$50.2K | 0.27% | 103 |
|
|
2023
Q3 | $214K | Buy |
+4,047
| New | +$214K | 0.2% | 114 |
|